Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-21

Clinical Trial Update: Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating glyburide vs placebo to prevent cerebral edema in patients undergoing radiosurgery for brain metastases; the study was terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cerebral Edema, Brain Metastases | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-09-21